Physician
Francisco J. Zarzar Mdpa
Francisco J. Zarzar Mdpa was paid $1.10M by Medicaid between Jan 2018 and Dec 2024, across 45 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 42% of everything it billed.
33Billing provider infoFRANCISCO J. ZARZAR MDPA
MISSION, TX 78572
MISSION, TX 78572
33aNPI1114249471assigned 02/26/2010
33bProvider typePediatrics Physician
28Total paid$1.10M
24GClaims45,836
24DCodes billed45
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#359 of 1,136
Median peer was paid$329K
This provider vs. median3.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 155 | $5K | |
| 2019 | 137 | $5K | |
| 2020 | 1,590 | $35K | |
| 2021 | 13,010 | $302K | |
| 2022 | 14,291 | $358K | |
| 2023 | 10,153 | $230K | |
| 2024incomplete | 6,500 | $162K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 42% | 12,837 | 10,646 | $457K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 9.1% | 1,333 | 1,261 | $100K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 8.4% | 2,542 | 2,265 | $92K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 7.7% | 1,085 | 1,020 | $84K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 7.6% | 6,581 | 5,859 | $83K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 7.1% | 5,933 | 2,867 | $78K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.3% | 941 | 894 | $69K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.6% | 3,133 | 1,638 | $28K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.5% | 4,487 | 4,050 | $27K |
| 99429 | 1.3% | 468 | 458 | $15K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.3% | 317 | 294 | $14K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.0% | 208 | 198 | $11K |
33 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 390 | $9K |
| 92567 | <1% | 477 | $6K | |
| 90461 | <1% | 913 | $4K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 56 | $4K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 229 | $2K |
| S8301 | Infection control supplies, not otherwise specified | <1% | 90 | $2K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 251 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 149 | $2K |
| 99051 | <1% | 571 | $2K | |
| 87807 | <1% | 145 | $2K | |
| 96160 | <1% | 1,021 | $1K | |
| 99383 | <1% | 12 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 52 | $607.92 |
| 92552 | <1% | 108 | $476.00 | |
| 99000 | <1% | 42 | $432.00 | |
| 36410 | <1% | 13 | $151.25 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 37 | $66.64 |
| 90658 | <1% | 641 | $36.91 | |
| 96161 | <1% | 48 | $2.25 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 36 | $0.00 |
| 90716 | 0% | 73 | $0.00 | |
| 90647 | 0% | 39 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 33 | $0.00 |
| 90651 | 0% | 49 | $0.00 | |
| 36416 | 0% | 71 | $0.00 | |
| 90620 | 0% | 16 | $0.00 | |
| 90670 | 0% | 77 | $0.00 | |
| 90633 | 0% | 44 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 63 | $0.00 |
| 99188 | 0% | 43 | $0.00 | |
| 90734 | 0% | 109 | $0.00 | |
| 90707 | 0% | 45 | $0.00 | |
| 90715 | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialZARZAR, FRANCISCO (PRESIDENT)